Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesc Valldeoriola

Showing results (151-160 of 170) with videos related to

Pageof 17
Sort By:
Plos One|July 16, 2015
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersClaustre Pont-Sunyer, Alex Iranzo, Carles Gaig, et al.
Neurology|October 18, 2015
Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorderFabienne S Sprenger, Nadia Stefanova, Ellen Gelpi, et al.
Annals of Neurology|August 5, 2022
Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation CarriersAlicia Garrido, Leticia Pérez-Sisqués, Cristina Simonet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2011
LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutationOswaldo Lorenzo-Betancor, Lluís Samaranch, Mario Ezquerra, et al.
Brain Sciences|August 27, 2021
Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi ProjectDiego Santos García, Marta Blázquez-Estrada, Matilde Calopa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
NPJ Parkinson'S Disease|June 8, 2026
Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect matchCelia Painous, Andrea Martínez, Ana Camara, et al.
Journal of Neurology|January 5, 2013
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewJens Volkmann, Alberto Albanese, Angelo Antonini, et al.
Antioxidants (Basel, Switzerland)|November 4, 2020
Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes MellitusDiana Luz Juárez-Flores, Mario Ezquerra, Ïngrid Gonzàlez-Casacuberta, et al.
European Journal of Neurology|January 16, 2026
Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic ReviewElisabetta Indelicato, Beatriz Carmona-Hidalgo, Javier Quintero, et al.
Pageof 17

Showing results (151-160 of 170) with videos related to

Sort By:
Pageof 17
Plos One|July 16, 2015
Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation CarriersClaustre Pont-Sunyer, Alex Iranzo, Carles Gaig, et al.
Neurology|October 18, 2015
Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorderFabienne S Sprenger, Nadia Stefanova, Ellen Gelpi, et al.
Annals of Neurology|August 5, 2022
Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation CarriersAlicia Garrido, Leticia Pérez-Sisqués, Cristina Simonet, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 1, 2011
LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutationOswaldo Lorenzo-Betancor, Lluís Samaranch, Mario Ezquerra, et al.
Brain Sciences|August 27, 2021
Present and Future of Parkinson's Disease in Spain: PARKINSON-2030 Delphi ProjectDiego Santos García, Marta Blázquez-Estrada, Matilde Calopa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 3, 2014
The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)Claustre Pont-Sunyer, Anna Hotter, Carles Gaig, et al.
NPJ Parkinson'S Disease|June 8, 2026
Synucleinopathy-like clinical features and biologically defined synuclein seeding in PSP-Parkinsonism: an imperfect matchCelia Painous, Andrea Martínez, Ana Camara, et al.
Journal of Neurology|January 5, 2013
Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewJens Volkmann, Alberto Albanese, Angelo Antonini, et al.
Antioxidants (Basel, Switzerland)|November 4, 2020
Disrupted Mitochondrial and Metabolic Plasticity Underlie Comorbidity between Age-Related and Degenerative Disorders as Parkinson Disease and Type 2 Diabetes MellitusDiana Luz Juárez-Flores, Mario Ezquerra, Ïngrid Gonzàlez-Casacuberta, et al.
European Journal of Neurology|January 16, 2026
Efficacy of Deep Brain Stimulation for the Treatment of Monogenic Dystonia Symptoms: A Systematic ReviewElisabetta Indelicato, Beatriz Carmona-Hidalgo, Javier Quintero, et al.
Pageof 17